ABBVIE BIOTECH VENTURES
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
ABBVIE BIOTECH VENTURES
Industry:
Biotechnology Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Apache COVID-19 Google Optimize 360 Amazon Elastic Load Balancing Sticky Session Amazon ALB SEO_H2 Adobe Experience Manager
Similar Organizations
BlueStone Venture Partners
BlueStone Venture Partners is a life science venture capital fund investing in entrepreneurial companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-06 | AmbAgon Therapeutics | AbbVie Biotech Ventures investment in Series A - AmbAgon Therapeutics | 85 M USD |
| 2021-11-02 | Nitrase Therapeutics | AbbVie Biotech Ventures investment in Series A - Nitrase Therapeutics | 7 M USD |
| 2021-10-26 | Quanta Therapeutics | AbbVie Biotech Ventures investment in Series C - Quanta Therapeutics | 60 M USD |
| 2021-08-18 | Jnana Therapeutics | AbbVie Biotech Ventures investment in Series B - Jnana Therapeutics | 50 M USD |
| 2021-08-17 | Starday Foods | AbbVie Biotech Ventures investment in Seed Round - Starday Foods | 4 M USD |
| 2021-07-15 | Stemson Therapeutics | AbbVie Biotech Ventures investment in Series A - Stemson Therapeutics | 15 M USD |
| 2021-06-14 | Ribon Therapeutics | AbbVie Biotech Ventures investment in Series C - Ribon Therapeutics | 65 M USD |
| 2021-03-03 | Caribou Biosciences | AbbVie Biotech Ventures investment in Series C - Caribou Biosciences | 115 M USD |
| 2021-03-01 | Carisma Therapeutics | AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics | 12 M USD |
| 2021-01-07 | Carisma Therapeutics | AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics | 47 M USD |
More informations about "AbbVie Biotech Ventures"
AbbVie Ventures investment portfolio | PitchBook
AbbVie Ventures has made numerous investments in companies like ThirtyFiveBio, Cephagenix, and Light Horse Therapeutics within the Biotechnology and Drug Discovery industries. What has AbbVie Ventures …See details»
AbbieVie Ventures - LaunchBio event
Mar 28, 2024 Calling all early-stage biotech and novel therapeutics companies! AbbVie Ventures is the strategic venture arm of AbbVie, with the mission to invest in transformational scientific …See details»
AbbVie - Crunchbase Company Profile & Funding
AbbVie is a biopharmaceutical company that develops pharmaceuticals and medical devices. The company provides products and services to therapeutic areas including immunology, …See details»
AbbVie Biotech Ventures Investor Information - Funding, Portfolio ...
AbbVie Biotech Ventures is a venture capital fund concentrating on biotech and deep tech sectors. They invest in early-stage companies to develop impactful medicines and solutions for …See details»
AbbVie Ventures Portfolio Investments, AbbVie Ventures Funds, …
Jan 8, 2024 About AbbVie Ventures AbbVie Ventures is a corporate venture arm of AbbVie dedicated to making venture capital investments in emerging biotech and pharmaceutical …See details»
Abbvie Biotech Ventures - Private Equity List
We’re AbbVie’s corporate strategic venture capital arm Investing since 2009, we focus exclusively on novel, transformational therapeutics at discovery and pre-clinical stages. Aligning with …See details»
AbbVie Biotech Ventures Venture Capital Profile | VentureDeal
AbbVie Biotech Ventures Venture Capital Profile | VentureDealSearch DOWNLOAD RECORD vCard | CSV | PDFSee details»
Funding Research & Development with AbbVie Ventures - Excedr
AbbVie Ventures —also known as AbbVie Biotech Venture—is a venture capital firm focused on investing in groundbreaking scientific research. By collaborating with leading scientists, it …See details»
Our Company | AbbVie
Our employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We’re constantly working to create solutions that go beyond treating the illness to have a …See details»
About AbbVie - Our Company | AbbVie
Our name represents our connection to the past and the future. When we became our own company, AbbVie formed a new kind of enterprise—a biopharmaceutical company. We blend the stability, global scale, resources and commercial …See details»
AbbVie Ventures Portfolio
Oct 24, 2024 Portfolio AbbVie Ventures is focused on early-stage opportunities in oncology, immunology, neuroscience, eye care, and aesthetics.See details»
How AbbVie aims to transform lives with early-stage ... - Nature
AbbVie Ventures is a key part of these efforts, investing in early-stage biotechs to help develop and validate life-changing treatments.See details»
AbbVie Biotech Ventures | IT History Society
AbbVie Biotech Ventures, an Illinois-based company, makes investments in emerging biotech and pharmaceutical companies.AbbVie is a global, research-based biopharmaceutical company …See details»
AbbVie | Investor profile | Foundersuite
AbbVie Biotech Ventures, Inc. (ABVI) is a subsidiary of AbbVie dedicated to making venture capital investments in emerging biotech and pharmaceutical companies. Unlike traditional …See details»
2023 Year In Review - abbvie.fr
Christian Schubert, MS, PhD Vice President and Head of AbbVie Ventures Christian is a trained geneticist, neurobiologist, and biochemist with global pharma and large biotech experience, …See details»
2024 Year In Review - AbbVie
AbbVie Ventures is dedicated to investing in science, people and ecosystems to shape tomorrow’s cures, driven by today’s innovators. The year 2024 proved to be a pivotal one for …See details»
Abbvie Biotech Ventures company information, funding
Abbvie Biotech Ventures, makes investments in emerging biotech and pharmaceutical companies. Here you'll find information about their funding, investors and team.See details»
AbbVie Biotech Ventures - venturecapitalarchive.com
Investment Thesis AbbVie Biotech Ventures aims to identify and support high potential biotech and pharmaceutical companies that can contribute to AbbVie's strategic goals and overall …See details»
Who We Are | AbbVie
Oct 24, 2024 AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.See details»
AbbVie snaps up CAR-T company in a deal worth $2.1 billion - STAT
5 days ago AbbVie announced it will acquire Capstan Therapeutics, a startup developing CAR-T therapies for autoimmune conditions, fibrosis, and cancer.See details»